Lower Ratings Shake Morale at NIH

WASHINGTON--One day last fall NIH lost one-half of its "outstanding" scientist administrators. Nobody left, and there was no immediate drop in the amount or quality of work being performed on the Bethesda campus. The change was strictly on paper, a result of a 1986 decision by the Reagan administration to reduce the number of “outstanding” performance ratings given to senior executives throughout the government. But NIH Director James Wyngaarden and others feel the policy delivers

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

But NIH Director James Wyngaarden and others feel the policy delivers a devastating blow to morale at an agency already struggling to staunch the flow of top scientists to universities and private industry. And a congressional oversight committee recently took top Health and Human Services Department officials to task for their "grotesquely unfair" actions and their "insensitivity" toward federal workers.

NIH historically has given the highest possible performance rating to a large proportion "as much as 80 percent"of its top administrators and scientists. Two years ago the Office of Personnel Management, in a decision embraced by HHS Secretary Otis Bowen, issued new guidelines to reverse what Bowen has called "rapid grade creep" in the evaluation of federal workers. OPM decided that 35 percent was a more reasonable figure; any agency that planned to classify as outstanding a higher percentage of its senior administrators would need to justify its decision.

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo